Travel Medicine and Infectious Disease | 2021

Sustainable border control policy in the COVID-19 pandemic: A math modeling study

 
 
 
 

Abstract


\n Background\n Imported COVID-19 cases, if unchecked, can jeopardize the effort of domestic containment. We aim to find out what sustainable border control options for different entities (e.g., countries, states) exist during the reopening phases, given their own choice of domestic control measures.\n \n Methods\n We propose a SUIHR model, which has built-in imported risk and (1-tier) contact tracing to study the cross-border spreading and control of COVID-19. Under plausible parameter assumptions, we examine the effectiveness of border control policies, in combination with internal measures, to confine the virus and avoid reverting back to more restrictive life styles again.\n \n Results\n When the basic reproduction number \n \n \n R\n 0\n \n \n of COVID-19 exceeds 2.5, even 100% effective contact tracing alone is not enough to contain the spreading. For an entity that has completely eliminated the virus domestically, and resumes “normal”, without mandatory institutional quarantine, even very strict border control measures combined with effective contact tracing can only delay another outbreak by 6 months. For entities employing a confining domestic control policy, non-increasing net imported cases is sufficient to remain open.\n \n Conclusions\n Extremely strict border control in entities, where domestic spreading is currently eliminated (e.g., China), is justifiable. However such harsh mesasure are not necessary for other places. Entities successfully confining the virus by internal measures can open up to similar entities without additional border controls so long as the imported risk stays non-increasing. Opening the borders to entities lacking sufficient internal control of the virus should be exercised in combination with pre-departure screening and tests upon arrival.\n

Volume 41
Pages 102044 - 102044
DOI 10.1016/j.tmaid.2021.102044
Language English
Journal Travel Medicine and Infectious Disease

Full Text